Thomas K Equels Aim Immuno Tech Inc. (AIM) insider trading activity
Thomas K Equels is CEO & President of AIM ImmunoTech Inc.. Currently has a direct ownership of 38,885 shares of AIM, which is worth approximately $353,853. The most recent transaction as insider was on Dec 13, 2021, when has been sold 21,552 shares (Common Stock) at a price of $1.16 per share, resulting in proceeds of $25,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
38.9K
98.99%
3M change
95.0%
12M change
Total Value Held
$353,853
Thomas K Equels Transaction History
TKE
Thomas K Equels
CEO & President
Ocala, FL